Phototherapy
Study results from State University of New York in the area of phototherapy published
Published in Drug Week, March 30th, 2007
Data detailed in "Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy" have been presented. According to a study from the United States, "We report energy-transferring organically modified silica nanoparticles for two-photon photodynamic therapy. These nanoparticles co-encapsulate two-photon fluorescent dye nanoaggregates as an energy up-converting donor and a photosensitizing PDT drug as an acceptor."
"They combine two features: (i) aggregation-enhanced two-photon absorption and emission properties of a novel two-photon dye and (ii)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-03-30)
More Articles from Drug Week
- Allergies
FDA Requests Label Change for All Sleep Disorder Drug Products - Alzheimer Disease
Computer predicts wishes of incapacitated patients better than family or loved ones - Anesthesia
Cocoa 'vitamin' health benefits could outshine penicillin - Angiogenesis
Two Novel Biologics Studied for Multiple Myeloma - Asthma
Safe Drug Compounding Act of 2007 Wins Favor with Consumer Health Alliance for Safe Medication - Behavior
Middle-Aged Adults Most Likely to Use Complementary Medicine - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
